Background

Cement implantation syndrome characterized by hypotension, hypoxemia, cardiac arrhythmia or arrest has been reported in the literature. The purpose of the present study was to monitor blood pressure soon after cementing.

Background

Impaction bone grafting (IBG) using a circumferential metal mesh is one of the options that allow restoration of the femoral bone stock and stability of the implant in hip arthroplasty. Here we examined the clinical and radiographic outcome of this procedure with a cemented stem and analyzed experimentally the initial stability of mesh–grafted bone–cemented stem complexes.

Purpose

One of the drawbacks of cemented total hip arthroplasty (THA) is aseptic loosening after long period, major reason for which is bioinertness of PMMA bone cement. To improve longevity of THA, interface bioactive bone cement (IBBC) technique which is characterized with smearing hydroxyapatite (HA) granules just before cementation has been used in our institute.

Purpose

Exeter stem was introduced to Japanese market at 1996. Since then, owing to its excellent clinical results, the number of the stem used has been increased year by year and more than 2000 stems have been implanted during the year 2009. The present study aims to prove its efficacy for Japanese patients by evaluating short term results of four major dedicated hip centers.

Purpose: Cement implantation syndrome characterized by hypotension, hypoxemia, cardiac arrhythmia or arrest has been reported in the literature. Pulmonary embolization is thought to be the main reason. In our institute, however, we have not experienced major hypotension during THA. To improve longevity of THA, interface bioactive bone cement technique combined with modern cementing technique has been used in our institute. Main principle of this technique is smearing hydroxyapatite granules on the dry bony surface followed by cement pressurization. The purpose of the present study was to monitor blood pressure soon after cementing.

Method: The present study includes 91 cases of primary THA with an average age at operation of 64 years old (ranging 35 to 85). Under general anesthesia, both components were cemented using antero-lateral approach. Systolic arterial blood pressure was monitored until 5 minutes with 1 minute interval. The maximum regulation (MR%) was calculated as (maximum change blood pressure – blood pressure before cement insertion) divided by blood pressure before cement insertion.

Results: No major complications such as cardiac arrest were observed. In most of the cases, blood pressure increased until 4 minutes for the acetabular side and 2 minutes for the femoral side, and then returned to the blood pressure before cement insertion gradually. In the acetabular side, MR% was 10±13 (−19–40)%. In 52 joints (57.1%), MR% was between 10 to 40 %. In the femoral side, MR% was 5±12 (−20 to 31)%. In 32 joints (35.2%), MR% was between 10 to 31 %.

Conclusion: In the present study, major hypotension was not observed. Blood pressure increases if left ventricle reacts to the pulmonary hypertension caused by micro-embolization. If major pulmonary embolization occurs, blood pressure decrease because left ventricle can not compensate for major pulmonary hypertension caused by mayor pulmonary embolization. By good cementing technique which includes washing out debris or fat and obtaining dry bony surface just before cementing, blood pressure soon after cementing was increased.

One of the drawbacks of cemented total hip arthroplasty (THA) is aseptic loosening after long period, major reason for which is bioinertness of PMMA bone cement. To improve longevity of THA, interface bio-active bone cement technique combined with modern cementing technique has been used in our institute, and was evaluated clinically and radiologically.

The present study includes 44 cases of primary THA with an average age at operation of 64 years old (ranging 48 to 81). Mean postoperative follow up period was 4 (ranging 3.5 to 5) years.

Pre- and postoperative evaluation using Merle d’Aubigné score were 8.0 and 16.2 points, respectively. Postoperative cementing grade using Barrack’s classification was A or B. At final follow up, radiolucent line at bone-cement interface was not observed, except one case of rheumatoid arthritis patient at zone 3 described by Delee and Charnley in the acetabular side. Neither osteolysis nor loosening was observed in every case. No major complications, such as infection, dislocation, pulmonary embolization, were observed.

The present study revealed excellent short-term result was obtained by IBBC technique combined with modern cementing technique for primary THAs. Most important technical point required for IBBC is to obtain dry bony surface just before cementing. Compressive reamed bone and gauze packing was effective for complete hemostasis just before cementing for the acetabular side, and plugging the isthmus using bone chips was effective for reducing bleeding for the femoral side.

Improved cement technique by interposing less than two layers of hydroxyapatite (HA) granules between bone and bone cement at the cementing (Interface Bio-active Bone Cement : IBBC) have been performed in total knee arthroplasty (TKA) since 1987.

We performed IBBC technique in 153 knees (130 patients) in TKA from 1987 to 1993. One hundred and forty knees (120 patients) could be followed up clinically and radiologically. Follow up rate was 91.5%. A mean follow-up period was 9.5 years (6 to 13 years) after surgery. As a control, clinical results of TKA with conventional cementing (Non-IBBC) which were operated in 44 knees (44 patients) in 1986 were used.

In IBBC cases, radiolucent lines on the tibial components were seen 7.1%, 2.9%, 1.4%, 3.6%, 0%, 0% and 0% at Zone ‡T to ‡Z of the anteroposterior view, while in Non-IBBC cases, 40.9%, 13.6%, 9.1%, 27.3%, 11.4%, 4.5% and 13.6% at Zone ‡T to ‡Z, respectively. In IBBC cases peri-prosthetic osteolysis of the tibial components were seen in three knees (2.1%), while 29.5% in Non-IBBC cases. Aseptic loosening of the tibial component was only one case (0.7%) in IBBC cases, while 9.1% in Non-IBBC cases.

In IBBC, bone cement bound to HA mechanically immediately after surgery and HA granules bound to the bone physicochemically after bone ingrowth into the spaces around the HA granules. In Non-IBBC, spaces will appear between bone and bone cement due to osteoporosis and/or atrophy after long years. However, in IBBC, bone and bone cement will contact by interposing HA forever due to osteoconductive effect of HA.

In conclusion, the IBBC has significantly reduced the incidence of radiolucent lines and periprosthetic osteolysis in TKAs. IBBC is a method combining the advantage of cementless HA coating and bone cement.

We have used Interface Bioactive Bone Cement (IBBC) in all cases of total joint arthroplasties since 1987. The method is improved cement technique by interposing less than two layers of hydroxyapatite (HA) granules between bone and the polymethylmethacrylate (PMMA) bone cement. We report one patient who underwent revision surgery after total knee arthroplasty (TKA) using IBBC.

The patient is a woman aged 70 years at the time of revision surgery. Right TKA was performed with the diagnosis of rheumatoid arthritis. An alumina ceramic total knee prosthesis was inserted using IBBC. Pain and walking ability were once improved after the primary TKA. However, the gait disturbance recurred after the patient fell on the ground. Radiographic findings showed severe genu varum, but neither radiolucent lines around the components nor migration of the components were seen. This was revised with semiconstrained prosthesis for the purpose of improving lateral instability at 31 months after the primary TKA.

Avulsion of fibular attachment of collateral ligament was seen at the time of the revision surgery. As PMMA cement was strongly adhered to the bone, it was removed together with cancellous bone. Histologically, HA granules bound to the bone directly after bone ingrowth into the spaces around the HA granules. This is the reason we have described IBBC as a method having the both advantages of cementless HA coating and PMMA bone cement.

After the revision surgery, the walking ability was improved.

In conclusion, this case showed excellent characteristics of IBBC.

We evaluated the efficacy and biocompatibility of porous apatite-wollastonite glass ceramic (AW-GC) as an intramedullary plug in total hip replacement (THR) for up to two years in 22 adult beagle dogs. Cylindrical porous AW-GC rods (70% porosity, mean pore size 200 3m) were prepared. Four dogs were killed at 1, 3, 6 and 12 months each and six at 24 months after implantation.

Radiological evaluation confirmed the efficacy of porous AW-CG as an intramedullary plug. Histological evaluation showed osteoconduction at one month and resorption of the porous AW-GC, which was replaced by newly-formed bone, at 24 months. Our findings indicate that porous AW-GC can be used clinically as an intramedullary plug in THR.